Immunome, Inc.
US ˙ NasdaqCM ˙ US45257U1088

SecurityIMNM / Immunome, Inc.
InstitutionTd Asset Management Inc
Latest Disclosed Ownership694,934 shares
Latest Disclosed Value $ 15,198,207
Td Asset Management Inc reports 8.46% decrease in ownership of IMNM / Immunome, Inc.

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 694,934 shares of Immunome, Inc. (US:IMNM) valued at $15,198,207 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 759,192 shares of Immunome, Inc.. This represents a change in shares of -8.46% during the quarter. The current value of the position is $12,911,874 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F IMMUNOME COM 45257U108 694,934 -64,258 -8.46 15,198 -6.80 0.0066
2026-02-10 2025-12-31 13F IMMUNOME COM 45257U108 759,192 57,912 8.26 16,307 98.60 0.0131
2025-11-10 2025-09-30 13F IMMUNOME COM 45257U108 701,280 95,750 15.81 8,212 45.82 0.0067
2025-07-28 2025-06-30 13F IMMUNOME COM 45257U108 605,530 -1,232 -0.20 5,631 37.91 0.0048
2025-05-07 2025-03-31 13F IMMUNOME COM 45257U108 606,762 183,460 43.34 4,084 -9.17 0.0038
2025-02-11 2024-12-31 13F IMMUNOME COM 45257U108 423,302 28,684 7.27 4,495 -20.78 0.0040
2024-11-01 2024-09-30 13F IMMUNOME COM 45257U108 394,618 69,412 21.34 5,675 44.23 0.0050
2024-08-02 2024-06-30 13F IMMUNOME COM 45257U108 325,206 39,400 13.79 3,935 -44.22 0.0037
2024-05-08 2024-03-31 13F IMMUNOME COM 45257U108 285,806 158,526 124.55 7,054 418.22 0.0066
2024-02-12 2023-12-31 13F IMMUNOME COM 45257U108 127,280 0 0.00 1,362 28.15 0.0013
2023-10-27 2023-09-30 13F IMMUNOME COM 45257U108 127,280 127,280 1,063 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.